G.J.S. Rustin
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment 17
- Obstetrics and Gynecology top 2%
- Oncology top 10%
- Surgery top 5%
- Testicular diseases and treatments 12
-
- Gestational Trophoblastic Disease Studies 12
- Reproductive Biology and Fertility 4
-
- Medical Imaging Techniques and Applications 4
-
- Prenatal Screening and Diagnostics 4
-
- Synthesis and biological activity 3
-
- Renal cell carcinoma treatment 3
G.J.S. Rustin
55 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 82
- Reproductive Medicine 870
- Obstetrics and Gynecology 276
- Oncology 455
- Surgery 731
- Public Health, Environmental and Occupational Health 307
Countries citing papers authored by G.J.S. Rustin
This map shows the geographic impact of G.J.S. Rustin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.J.S. Rustin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.J.S. Rustin more than expected).
Fields of papers citing papers by G.J.S. Rustin
This network shows the impact of papers produced by G.J.S. Rustin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.J.S. Rustin. The network helps show where G.J.S. Rustin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G.J.S. Rustin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomised double-blind phase III trial of cediranib (AZD 2171) in relapsed platinum sensitive ovarian cancer: Results of the ICON6 trial | 2013 | 75 |
| 2 | 2005 | 20 | |
| 3 | 2004 | 1 | |
| 4 | Phase I clinical trial of weekly combrestatin A4 phosphate (CA4P) clinical and pharmacokinetic results | 2003 | 1 |
| 5 | 2001 | 5 | |
| 6 | 1999 | 5 | |
| 7 | 1997 | 83 | |
| 8 | 1996 | 21 | |
| 9 | 1996 | 312 | |
| 10 | 1996 | 216 | |
| 11 | 1993 | 59 | |
| 12 | 1993 | 5 | |
| 13 | 1993 | 20 | |
| 14 | 1992 | 6 | |
| 15 | 1992 | 69 | |
| 16 | 1990 | 9 | |
| 17 | 1989 | 41 | |
| 18 | 1989 | 38 | |
| 19 | 1989 | 73 | |
| 20 | 1988 | 40 |
About G.J.S. Rustin
G.J.S. Rustin is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health, Obstetrics and Gynecology, Surgery and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (17 papers), Gestational Trophoblastic Disease Studies (12 papers), Testicular diseases and treatments (12 papers), Medical Imaging Techniques and Applications (4 papers), Reproductive Biology and Fertility (4 papers), Prenatal Screening and Diagnostics (4 papers), Synthesis and biological activity (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Reproductive Medicine (870 citations), Obstetrics and Gynecology (276 citations), Oncology (455 citations), Surgery (731 citations) and Public Health, Environmental and Occupational Health (307 citations). G.J.S. Rustin has collaborated with scholars based in United Kingdom, United States and Norway. Frequent co-authors include Ann E. Nelstrop, H Lambert, E.S. Newlands, Malgorzata Tuxen, Hugh Mitchell, M F Brady, William P. McGuire, W.J. Hoskins, Walter M. Gregory and K. D. Bagshawe. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, International Journal of Gynecology & Obstetrics and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.